SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹825 Cr | ₹86 Cr | ₹72 Cr | ₹92 Cr | ₹74 Cr |
What is the latest Total Non-Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹825 Cr |
| Mar2024 | ₹86 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹74 Cr |
How is Total Non-Current Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹825 Cr | 859.40 | |
| Mar2024 | ₹86 Cr | 19.83 | |
| Mar2023 | ₹72 Cr | -22.06 | |
| Mar2022 | ₹92 Cr | 24.63 | |
| Mar2021 | ₹74 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹14,571.3 Cr | -0.9% | -29.2% | -63.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -0.9% |
-29.2% |
-63.4% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses